Century Therapeutics Inc

General ticker "IPSC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $114.6M

Century Therapeutics Inc does not follow the US Stock Market performance with the rate: -30.0%.

Estimated limits based on current volatility of 4.1%: low 1.01$, high 1.09$

Factors to consider:

  • Current price 37.0% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.62$, 4.14$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.25$, 5.24$]

Financial Metrics affecting the IPSC estimates:

  • Negative: Non-GAAP EPS, $ of -2.13 <= 0.10
  • Negative: Operating profit margin, % of -98.50 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -40.84 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term IPSC quotes

Long-term IPSC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $5.20MM $2.23MM
Operating Expenses $94.88MM $139.03MM $148.78MM
Operating Income $-94.88MM $-133.83MM $-146.55MM
Non-Operating Income $-0.90MM $2.99MM $11.75MM
Interest Expense $0.90MM $0.00MM $0.54MM
R&D Expense $75.65MM $107.17MM $92.71MM
Income(Loss) $-95.78MM $-130.84MM $-134.79MM
Taxes $0.04MM $0.09MM $1.88MM
Profit(Loss) $-95.82MM $-130.93MM $-136.67MM
Stockholders Equity $396.24MM $302.74MM $184.75MM
Inventory $0.25MM $0.00MM $0.00MM
Assets $437.38MM $486.54MM $360.69MM
Operating Cash Flow $-89.00MM $14.05MM $-88.35MM
Capital expenditure $44.97MM $30.60MM $13.74MM
Investing Cash Flow $-298.34MM $-13.13MM $61.13MM
Financing Cash Flow $417.77MM $27.16MM $-9.72MM
Earnings Per Share* $-1.74 $-2.27 $-2.30

* EPS are Split Adjusted, recent splits may be reflected with a delay.